THE DEAL, AT A GLANCE
From the announcementAspen Neuroscience
01What happenedAspen Neuroscience raised $115M Series CFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Why it mattersAspen Neuroscience is using its Series C financing to advance personalized cell therapy programs, with Parkinson's disease as the stated area of focus.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Aspen Neuroscience · Financing Record
Explore source-linked visual explanations for Aspen Neuroscience. Unsupported claims are withheld while source review continues.
Record 2204 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →